• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Predicting Tumor Response to PD-1 Blockade.

作者信息

Ding Li, Chen Feng

机构信息

From the Department of Medicine (L.D., F.C.), McDonnell Genome Institute (L.D.), the Department of Genetics (L.D.), Siteman Cancer Center (L.D., F.C.), and the Department of Cell Biology and Physiology (F.C.) - all at Washington University School of Medicine, St. Louis.

出版信息

N Engl J Med. 2019 Aug 1;381(5):477-479. doi: 10.1056/NEJMcibr1906340.

DOI:10.1056/NEJMcibr1906340
PMID:31365807
Abstract
摘要

相似文献

1
Predicting Tumor Response to PD-1 Blockade.预测肿瘤对PD-1阻断疗法的反应。
N Engl J Med. 2019 Aug 1;381(5):477-479. doi: 10.1056/NEJMcibr1906340.
2
Mismatch Repair Deficiency and Response to Immune Checkpoint Blockade.错配修复缺陷与免疫检查点阻断反应
Oncologist. 2016 Oct;21(10):1200-1211. doi: 10.1634/theoncologist.2016-0046. Epub 2016 Jul 13.
3
Engineering Tumor Hypersusceptibility to Checkpoint Immunotherapy.工程化肿瘤对免疫检查点疗法的超敏感性
Trends Cancer. 2017 Oct;3(10):675-677. doi: 10.1016/j.trecan.2017.08.002. Epub 2017 Sep 4.
4
Pan-tumor genomic biomarkers for PD-1 checkpoint blockade-based immunotherapy.泛肿瘤基因组生物标志物用于基于 PD-1 检查点阻断的免疫治疗。
Science. 2018 Oct 12;362(6411). doi: 10.1126/science.aar3593.
5
Nivolumab in the treatment of microsatellite instability high metastatic colorectal cancer.纳武利尤单抗治疗微卫星高度不稳定转移性结直肠癌。
Future Oncol. 2018 Aug;14(18):1869-1874. doi: 10.2217/fon-2017-0696. Epub 2018 Feb 23.
6
Genetic diversity of tumors with mismatch repair deficiency influences anti-PD-1 immunotherapy response.错配修复缺陷肿瘤的遗传多样性影响抗 PD-1 免疫治疗反应。
Science. 2019 May 3;364(6439):485-491. doi: 10.1126/science.aau0447.
7
Biomarkers for immune therapy in gastrointestinal cancers.胃肠道癌症免疫治疗的生物标志物
Clin Adv Hematol Oncol. 2019 Feb;17(2):109-119.
8
Microsatellite Instability Predicts Response to Anti-PD1 Immunotherapy in Metastatic Melanoma.微卫星不稳定性预测转移性黑色素瘤对抗PD1免疫疗法的反应。
Acta Dermatovenerol Croat. 2018 Dec;26(4):341-343.
9
Why is immunotherapy effective (or not) in patients with MSI/MMRD tumors?为什么免疫疗法对微卫星高度不稳定/错配修复缺陷（MSI/MMRD）肿瘤患者有效（或无效）？
Bull Cancer. 2019 Feb;106(2):105-113. doi: 10.1016/j.bulcan.2018.08.007. Epub 2018 Oct 17.
10
Efficacy of PD-1 Blockade in Refractory Microsatellite-Stable Colorectal Cancer With High Tumor Mutation Burden.PD-1阻断剂在具有高肿瘤突变负荷的难治性微卫星稳定型结直肠癌中的疗效
Clin Colorectal Cancer. 2019 Dec;18(4):307-309. doi: 10.1016/j.clcc.2019.08.001. Epub 2019 Sep 4.

引用本文的文献

1
Research progress of paclitaxel nanodrug delivery system in the treatment of triple-negative breast cancer.紫杉醇纳米药物递送系统治疗三阴性乳腺癌的研究进展
Mater Today Bio. 2024 Nov 23;29:101358. doi: 10.1016/j.mtbio.2024.101358. eCollection 2024 Dec.
2
Gemogenovatucel-T (Vigil): bi-shRNA plasmid-based targeted immunotherapy.杰莫尼莫他特（唯择）：基于 bi-shRNA 质粒的靶向免疫治疗。
Future Oncol. 2024;20(29):2149-2164. doi: 10.1080/14796694.2024.2376518. Epub 2024 Aug 5.
3
Decoding the Expressions, Immune Relevance, and Prognostic Values of Ferroptosis Gene TMEM189: A Pan-cancer Analysis.
解析铁死亡基因TMEM189的表达、免疫相关性及预后价值：一项泛癌分析
Curr Cancer Drug Targets. 2025;25(5):520-537. doi: 10.2174/0115680096308701240605114342.
4
Mismatch repair gene correlates with the prognosis, immune status and immune checkpoint inhibitors response of endometrial cancer.错配修复基因与子宫内膜癌的预后、免疫状态和免疫检查点抑制剂反应相关。
Front Immunol. 2024 Feb 8;15:1302797. doi: 10.3389/fimmu.2024.1302797. eCollection 2024.
5
Prediction of Prognosis, Immunotherapy and Chemotherapy with an Immune-Related Risk Score Model for Endometrial Cancer.基于免疫相关风险评分模型的子宫内膜癌预后、免疫治疗和化疗预测
Cancers (Basel). 2023 Jul 19;15(14):3673. doi: 10.3390/cancers15143673.
6
A novel pyroptosis-associated lncRNA LINC01133 promotes pancreatic adenocarcinoma development via miR-30b-5p/SIRT1 axis.一种新型与细胞焦亡相关的长链非编码 RNA LINC01133 通过 miR-30b-5p/SIRT1 轴促进胰腺腺癌的发展。
Cell Oncol (Dordr). 2023 Oct;46(5):1381-1398. doi: 10.1007/s13402-023-00818-5. Epub 2023 May 4.
7
Targeting the alterations of ARID1A in pancreatic cancer: tumorigenesis, prediction of treatment, and prognostic value.针对胰腺癌中ARID1A的改变：肿瘤发生、治疗预测及预后价值
Am J Transl Res. 2022 Sep 15;14(9):5952-5964. eCollection 2022.
8
Telomere Shortening in Peripheral Leukocytes Is Associated With Poor Survival in Cancer Patients Treated With Immune Checkpoint Inhibitor Therapy.外周血白细胞端粒缩短与接受免疫检查点抑制剂治疗的癌症患者生存率低相关。
Front Oncol. 2021 Aug 19;11:729207. doi: 10.3389/fonc.2021.729207. eCollection 2021.
9
Exploration of a Robust and Prognostic Immune Related Gene Signature for Cervical Squamous Cell Carcinoma.探索一种用于宫颈鳞状细胞癌的稳健且具有预后价值的免疫相关基因特征。
Front Mol Biosci. 2021 Mar 3;8:625470. doi: 10.3389/fmolb.2021.625470. eCollection 2021.
10
Nanosonosensitizer-Augmented Sonodynamic Therapy Combined with Checkpoint Blockade for Cancer Immunotherapy.纳米声敏剂增强的声动力学疗法联合免疫检查点阻断用于癌症免疫治疗。
Int J Nanomedicine. 2021 Mar 5;16:1889-1899. doi: 10.2147/IJN.S290796. eCollection 2021.